As the invasive Asian longhorned tick (Haemaphysalis longicornis) spreads across the eastern and central U.S., cattle producers face an escalating threat: Theileria orientalis Ikeda. The tick-borne protozoan parasite destroys red blood cells and causes bovine infectious anemia, leaving affected cattle lethargic, anemic and prone to reproductive failure or death.
Compounding the problem, there have been no approved treatments for Theileria in the U.S., and surviving cattle remain persistently infected carriers for life. Now, cattlemen have their first targeted tool to use. Brookings, S.D.-based animal health company Medgene has rolled out the first platform vaccine targeting Theileria for beef and dairy cattle.
A Growing Threat with High Stakes
First detected in 2017, the Asian longhorned tick has since established populations across more than 19 states. Where the tick goes, Theileria often follows.
Unlike bovine anaplasmosis — which rarely causes severe clinical disease in young calves — Theileria hits calves and pregnant heifers especially hard. Clinical signs include fever, severe anemia, jaundice, lethargy, abortions and sudden death, with mortality rates reaching up to 50% in naive animals during acute outbreaks.
Because infected ticks can survive in pastures for up to two years and spread rapidly through a herd before clinical signs are detected, preparation and planning prior to outbreaks are critical.
How the Platform Vaccine Works
Medgene utilizes a USDA-regulated platform technology that creates subunit protein vaccines. Rather than growing the whole organism or relying on a modified-live pathogen, Medgene’s platform vaccine uses a baculovirus vector system to synthesize only the specific target antigen.
In the case of Theileria, the vaccine targets the parasite’s Major Piroplasm Surface Protein (MPSP) across multiple life stages.
“We just make that antigen component that goes into our vaccine — the part that the immune system actually latches onto in order to recognize the Theileria pathogen,” says Dr. Will McCauley, Medgene director of industry and government relations. “Since Theileria is a relatively new disease in the U.S. with no other products available, we are on the leading edge. Our platform allows us to step up and provide veterinarians and cattle producers a viable tool right now.”
Three Key Use Cases for Beef Producers
McCauley outlines several potential management scenarios where producers should consider implementing the vaccine in consultation with their herd veterinarian:
- Cow-Calf Herds in Frontline and Endemic Areas: Operations located where the Asian longhorned tick is established or actively encroaching.
- Naive Breeding Stock Entering Endemic Zones: High-value seedstock bulls or replacement heifers purchased from non-affected regions and transported into tick-endemic states.
- Known Positive Cattle Facing Stress Events: Animals that have survived an acute Theileria infection but are scheduled for transport to a feedlot, weaning, castration or processing. Stress can trigger clinical relapses or severe performance lag.
Protocol and Administration
The Theileria vaccine is a killed product that requires a two-dose primary series administered four weeks (one month) apart, with an additional dose(s) as recommended by a veterinarian to maintain antibody levels.
Because it is regulated as a prescription platform biologic, the vaccine is not available over the counter. Producers must obtain it directly through a licensed veterinarian with an established Veterinarian-Client-Patient Relationship (VCPR).
Diagnostics: Don’t Confuse Theileria with Anaplasmosis
McCauley cautions producers not to rely solely on visual symptoms when diagnosing herd issues. While Theileria and anaplasmosis share nearly identical clinical signs — fever, pale gums, jaundice and weakness — the Theileria vaccine does not protect against anaplasmosis.
“They present very similarly clinically and pathologically,” McCauley notes. “You won’t know for certain what you are dealing with without laboratory diagnostics. Producers should work closely with their veterinarian to pull blood samples and confirm the pathogen before designing a vaccination and management strategy.”
Looking Ahead
With federal lawmakers also introducing supportive measures such as the Emerging Tick-Borne Livestock Disease Research Prioritization Act, tick control and pathogen prevention are moving to the forefront of national herd health policy.
For producers operating in or shipping cattle through tick-prone areas, proactive herd health planning is key.
“Anyone currently dealing with Theileria or facing the prospect of the Asian longhorned tick moving onto their pasture should contact their veterinarian,” McCauley summarizes. “Putting a plan together before an outbreak hits the herd is the best way to safeguard productivity and profitability.”
Your Next Reads:
